Weight Loss Jabs and Cancer: What the Research Says

GLP-1 receptor agonists like semaglutide, and dual GIP/GLP-1 receptor agonists like tirzepatide, have been studied extensively in clinical trials. To date, no causal link between these medicines and cancer in humans has been established from that trial data.

The thyroid question

One area that comes up frequently is thyroid cancer. In animal studies, GLP-1 receptor agonists were associated with thyroid C-cell tumours in rodents — but regulatory agencies and researchers note that the relevance of this finding to humans remains unclear. As a precaution, these medicines are generally not recommended for people with a personal or family history of certain thyroid conditions; your prescriber will have considered this when they wrote your prescription. If you have thyroid concerns, raise them directly with your healthcare professional.

Observational research and ongoing studies

Some large observational studies have suggested possible protective associations between GLP-1 medicines and certain cancer types, while others have flagged areas needing further investigation. Observational research can identify patterns but cannot on its own prove cause and effect. This is an active area of scientific inquiry, and guidance may evolve as more data emerges.

Because these are prescription-only medicines subject to ongoing safety monitoring, side effects and safety signals are tracked through national pharmacovigilance schemes. If you experience any unexpected symptoms, you can report them to your national reporting scheme (such as the UK's Yellow Card scheme) and inform your prescriber or doctor.

For a broader understanding of how weight loss injections work and what to expect, including general safety considerations, our main guide covers the topic in detail. You may also find it useful to read about Mounjaro specifically as a weight loss jab if tirzepatide is what you have been prescribed.

If you are already prescribed one of these medicines, keeping a clear record of how you feel over time is genuinely valuable — both for your own peace of mind and for conversations with your prescriber.

The most relevant GLP Trackr feature here is side-effect tracking. You can log any symptom — whether that is an injection-site reaction, an unexpected change in how you feel, or anything else you want to flag — and the app builds a timeline of entries that you can bring to your next appointment. Rather than trying to recall weeks of symptoms from memory, you arrive with a clear, dated record.

Alongside that, the doctor report feature compiles your logged data — symptoms, doses, weight trends — into a summary designed to support a productive conversation with your healthcare professional. If you have concerns about any new or persistent symptom, that summary can help your prescriber understand the full picture quickly.

GLP Trackr also logs each injection: dose strength, date, and injection site. Consistent tracking means nothing gets forgotten, and your prescriber has accurate information to work with. You can explore more about what weight loss jabs involve day to day, or read about how these medicines are typically accessed through a prescriber and pharmacy.

If you notice any symptom that is severe, persistent, or worrying, contact your healthcare professional promptly — do not wait for your next scheduled appointment. GLP Trackr is a tracking tool; it is not a substitute for clinical assessment, and any concern about your health should go to your prescriber or doctor first.

Log your symptoms and track your journey with confidence — download GLP Trackr free on the App Store or Google Play and start a 7-day trial at no cost.